Sareum (LON:SAR) Stock Price Crosses Above 50-Day Moving Average – Here’s Why
by Amy Steele · The Cerbat GemSareum Holdings plc (LON:SAR – Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 16.43 and traded as high as GBX 21.68. Sareum shares last traded at GBX 21.50, with a volume of 148,169 shares traded.
Sareum Trading Down 4.1%
The stock has a market cap of £27.79 million, a P/E ratio of -5.16 and a beta of -1.08. The firm’s 50-day simple moving average is GBX 16.53 and its 200 day simple moving average is GBX 16.12.
Sareum (LON:SAR – Get Free Report) last posted its earnings results on Thursday, March 12th. The company reported GBX (1.20) EPS for the quarter. On average, analysts anticipate that Sareum Holdings plc will post -3.8 EPS for the current year.
About Sareum
Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.